HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Reaction

3,5-Dichlorosalicylaldehyde → cyclopentanecarboxylic acid [3-(3,5-dichloro-2-hydroxybenzyl)-2-oxo-2,3-dihydro-1H-indol-6-yl]-amide

HRID 2120203
Print

Reaction equation

HRID 2120203 reaction equation
O=C1CC2C(=CC(NC(C3CCCC3)=O)=CC=2)N1.ClC1C=C(Cl)C=C(C=O)C=1O.[Cl:30][C:31]1[C:32]([OH:57])=[C:33]([CH:53]=[C:54]([Cl:56])[CH:55]=1)[CH:34]=[C:35]1[C:43]2[C:38](=[CH:39][C:40]([NH:44][C:45]([CH:47]3[CH2:51][CH2:50][CH2:49][CH2:48]3)=[O:46])=[CH:41][CH:42]=2)[NH:37][C:36]1=[O:52]>>[Cl:30][C:31]1[C:32]([OH:57])=[C:33]([CH:53]=[C:54]([Cl:56])[CH:55]=1)[CH2:34][CH:35]1[C:43]2[C:38](=[CH:39][C:40]([NH:44][C:45]([CH:47]3[CH2:51][CH2:50][CH2:49][CH2:48]3)=[O:46])=[CH:41][CH:42]=2)[NH:37][C:36]1=[O:52]
ParticipantsProcedureWorkupSources & evidenceReaction notes

Participants

4

Reactant 3

HCID 666603,5-DichlorosalicylaldehydeHCID 54077377cyclopentanecarboxylic acid [3-(3,5-dichloro-2-hydroxy-benzylidene)-2-oxo-2,3-dihydro-1H-indol-6-yl]-amideHCID 54539339Cyclopentanecarboxylic acid (2-oxo-2,3-dihydro-1H-indol-6-yl)-amide

Product 1

HCID 57096104cyclopentanecarboxylic acid [3-(3,5-dichloro-2-hydroxybenzyl)-2-oxo-2,3-dihydro-1H-indol-6-yl]-amideYield 40%

Procedure

Cyclopentanecarboxylic acid (2-oxo-2,3-dihydro-1H-indol-6-yl)-amide was condensed with 3,5-dichlorosalicylaldehyde using method B to give a mixture of isomers of cyclopentanecarboxylic acid [3-(3,5-dichloro-2-hydroxy-benzylidene)-2-oxo-2,3-dihydro-1H-indol-6-yl]-amide as an orange solid which was reduced using method D to give 10 mg (40%) of cyclopentanecarboxylic acid [3-(3,5-dichloro-2-hydroxybenzyl)-2-oxo-2,3-dihydro-1H-indol-6-yl]-amide as an off-white crystalline solid.

Workup

  1. customto give

Sources & evidence

ORD record
ord-0bec4b20e71b433ca039e7b530479732
Source dataset
uspto-grants-2004_02
DOI
10.6084/m9.figshare.5104873.v1
Patent number
US06689806B1

Reaction notes

On this pageParticipantsProcedureWorkupSources & evidenceReaction notes